Holly has a background in healthcare and specialises in life sciences technology commercialisation, programme management and training.
Holly joined Oxentia in 2018 as a senior consultant and core member of Oxentia’s Entrepreneurship and Accelerators Services team. She specialises in technology commercialisation, innovation strategy, and entrepreneurship. Holly helps clients to develop strategies for market entry and build innovation capability in their organisations.
At Oxentia, Holly has worked with mature organisations seeking to create new value and growth through innovation as well with new organisations going through their start-up phase. She also plays a key role in developing and implementing training and mentoring programmes for groups of entrepreneurs around the world. Holly has a focus on encouraging investment and innovation for social and economic impact.
Holly has had extensive experience in healthcare and medical technology, including commercialisation of digital solutions for the life science market.
Outside Oxentia, Holly enjoys triathlon training, baking goodies for the office and eating spicy food.
- Innovation strategy
- Early stage investing
- Impact Investing
- Medical devices and digital health technology
- MBA, Henley Business School
- MSc, Seton Hall University
- BSc, Rutgers University
- United States Army, Academy of Health Sciences